Naim Alkhouri

Naim Alkhouri

Company: Arizona Liver Health

Job title: Director, Fatty Liver Program, Vice President of Academic Affairs


The Use of Combination Biomarkers & Combination Medications to Treat Nonalcoholic Steatohepatitis (NASH): The Combo-Combo Approach 11:15 am

Describe current biomarkers and therapeutic agents for nonalcoholic steatohepatitis Looking at the Phase II proof-of-concept trial alongside Gilead & NovoNordisk (utilising exploratory biomarker endpoints) Insight to shape future clinical strategy based on clinical findings & dataRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.